Sitav Elturan

The Non-Opioid Pain Therapeutics Summit provides a dedicated platform to harness the current momentum in the pain space. Attendees will be learning from companies with approvals such as Tonix and Vertex, exploring late-stage strategies from innovators like Latigo and Algiax, and uncovering discovery breakthroughs from Nocion and Axonis. Join discovery, preclinical, translational and clinical industry-based experts driving the future of non-opioid pain therapies.

OSD Early Stage: Getting Oral Products Into Clinic Early Strategic formulation choices and early solubility screening are vital for overcoming poor solubility and limited supply to accelerate the path to first-in-human trials and stand up to the pressure. API In Capsule Vs. The Lost Art Of Formulation Development API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development.

Friendshoring: A Strategic Shift In Pharma Supply Chains To safeguard the consistent delivery of essential therapies to patients around the world, biopharmaceutical companies, alongside their CDMO partners, are rethinking traditional supply models. Early-Stage Drug Development: Trends Shaping Tomorrow's Therapies From AI to adaptive trial designs, the industry is undergoing a transformation that is equal parts scientific and strategic. Learn about the innovations poised to redefine pipelines.